Severe mucositis: How can nutrition help?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 5, 2007, Pages 627-631

  Keefe, Dorothy M ^a,b   Rassias, Georgina ^a   O'Neil, Lisa ^a   Gibson, Rachel J ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cancer; Chemotherapy; Mucositis; Nutrition; Radiotherapy

Indexed keywords

IRINOTECAN; PROBIOTIC AGENT;

CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIET THERAPY; DIETARY FIBER; DISEASE SEVERITY; FOOD COMPOSITION; HUMAN; INCIDENCE; MUCOSA INFLAMMATION; NEUTROPENIA; NONHUMAN; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PARENTERAL NUTRITION; REVIEW;

ANTINEOPLASTIC AGENTS; HUMANS; MUCOSITIS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; RISK FACTORS;

EID: 34547901110     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3282bf90d6     Document Type: Review

References (26)

1. Keefe D. Mucositis guidelines: what have they achieved and where to from here [Invited Editorial]. Support Care Cancer 2006; 14:489-491. An excellent summary of the current mucositis guidelines.
2. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hyperplasia in crypts of the small intestine in humans. Gut 2000; 47:632-637.
3. Gibson RJ, Keefe DMK. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage, possible prevention strategies and treatment of the clinical problem. Support Care Cancer 2006; 14:890-900.
4. Ollenschlager G, Thomas W, Konkol K, et al. Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia. Euro J Clin Invest 1991; 22:546-553.
5. Kern KA, Norton JA. Cancer cachexia. JPEN 1998; 12:286-298.
6. Ottery FD. Rethinking nutritional support of the cancer patient: the new field of nutritional oncology. Semin Oncol 1994; 21:770-778.
7. Palomares MR, Sayre JW, Shekar KC, et al. Gender influence of weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 1996; 78:2119-2126.
8. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996; 12 (1 Suppl):S15-S19.
9. Nittenberg G, Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Haematol 2000; 34:137-168.
10. Antoun S, Merad M, Raynard B, Ruffie P. Malnutrition in cancer patients. Rev Prat 2006; 56:2025-2029.
11. American Dietetic Association. Identifying patients at risk: ADA's definitions for nutrition screening and assessment. JADA 1994; 94: 838-839.
12. Dietitians Association of Australia (DAA). Evidence Based Practice Guidelines for Nutritional Management of Cancer Cachexia 2005; 1-31.
13. Bauer J, Capra S. Intensive nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy: a pilot study. Support Care Cancer 2005; 13:270-274.
14. Barrera R. Nutritional support in cancer patients. JPEN 2002; 26:S63-S71.
15. Van Bokhorst-de van der Schueren MA. Nutritional support strategies for malnourished cancer patients. Eur J Oncol Nurs 2005; 9 (Suppl 2):S74-S83.
16. Staal-van den Breckel AJ, Schols AM, Dentener MA, et al. Metabolism in patients with small cell lung carcinoma compared with nonsmall cell lung carcinoma and healthy controls. Thorax 1997; 52:338-341.
17. Jatoi A, Daly BD, Hughes VA, et al. Do patients with nonmetastatic nonsmall cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg 2001; 72:348-351.
18. Long CL, Schaffel N, Geiger JW, et al. Metabolic response to injury and illness: estimation of energy and protein needs from indirect calorimetry and nitrogen balance. JPEN 1979; 3:452-456.
19. Davidson W, Ash S, Capra S, Bauer J. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 2004; 23:239-247.
20. Barasch A, Elad S, Altman A, et al. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 2006; 14:528-532. This is one of the only studies in the past 12 months that discusses the role of nutrition and alimentary mucositis. As such, it is an excellent paper for review.
21. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 2003; 39:91-100.
22. Pytlik R. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind placebo-controlled study. Bone Marrow Transplant 2002; 20:953-961.
23. Peterson DE, Jones JB, Petit RG II. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving antracycline-based chemotherapy. Cancer 2007; 109:322-331. An interesting study discussing the role of Saforis and oral mucositis.
24. Thornley I. A multiagent strategy to decrease redimen-related toxicity in children undergoing allogenic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10:635-644.
25. Sanford K. Reintroduction to nutrition and cancer treatment. Seminars in Oncology Nursing 2005; 21:164-174.
26. Aprile G, Ramoni M, Keefe D, Sonis S. Network analysis to define chemotherapy toxicity clusters in patients with colorectal cancer (CRC), 2007. ASCO Annual Meeting Proceedings. JCO.25 (18S). Abstract 9045.